2504 related articles for article (PubMed ID: 26933039)
1. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
2. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
4. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
[TBL] [Abstract][Full Text] [Related]
5. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
6. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of cell-intrinsic regulators in the process of differentiation of human iPSCs into retinal lineages.
Chuang JH; Yarmishyn AA; Hwang DK; Hsu CC; Wang ML; Yang YP; Chien KH; Chiou SH; Peng CH; Chen SJ
Stem Cell Res Ther; 2018 May; 9(1):140. PubMed ID: 29751772
[TBL] [Abstract][Full Text] [Related]
9. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
[TBL] [Abstract][Full Text] [Related]
10. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
Tesarova L; Simara P; Stejskal S; Koutna I
PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
[TBL] [Abstract][Full Text] [Related]
11. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
Hazim RA; Karumbayaram S; Jiang M; Dimashkie A; Lopes VS; Li D; Burgess BL; Vijayaraj P; Alva-Ornelas JA; Zack JA; Kohn DB; Gomperts BN; Pyle AD; Lowry WE; Williams DS
Stem Cell Res Ther; 2017 Oct; 8(1):217. PubMed ID: 28969679
[TBL] [Abstract][Full Text] [Related]
13. Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells.
Sridhar A; Steward MM; Meyer JS
Stem Cells Transl Med; 2013 Apr; 2(4):255-64. PubMed ID: 23512959
[TBL] [Abstract][Full Text] [Related]
14. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
Ebrahimi B
Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells.
Bhise NS; Wahlin KJ; Zack DJ; Green JJ
Int J Nanomedicine; 2013; 8():4641-58. PubMed ID: 24348039
[TBL] [Abstract][Full Text] [Related]
16. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
17. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
Durruthy JD; Sebastiano V
Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
[TBL] [Abstract][Full Text] [Related]
18. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
Chen Y; Yi Y; Xu J; Chan WK; Loh YH
FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
[TBL] [Abstract][Full Text] [Related]
19. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
20. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]